Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,361
Recruiting: 790
Ph III recruiting: 74
Growth YoY: +9.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (646)

clinicaltrialsPublishedShowing 5,151–5,154 of 5,154 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00043433	Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.	unknown	Phase 2	35	TularikINDUSTRY	2	Jun 24, 2005	clinicaltrials
NCT00054951	Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads	unknown	Phase 1 / Phase 2	30	FeRxINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00057382